Stay updated on Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial page
- ChecktodayChange DetectedThe page footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check7 days agoChange DetectedA sitewide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference0.7%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check21 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page history shows a new revision entry, replacing the previous revision. This indicates an update to the study record's version (from v3.6.6 to v3.7.0).SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry, v3.6.6, was added to the study's history. The previous revision, v3.6.5, was removed from the history view.SummaryDifference0.1%

Stay in the know with updates to Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial page.